IP Library Granted Patent US 10,893,903
Granted Patent B2
US 10,893,903 · App. 16/155,821 · Granted Jan 19, 2021

Medical instruments having contact assessment features

Inventors: Josef Vincent Koblish (Sunnyvale, CA); Donghoon Chun (Sunnyvale, CA); Jessi E. Johnson (Sunnyvale, CA)
Assignee: Epix Therapeutics, Inc.
A61B18/1492A61B5/0538A61B5/4836A61B5/6885A61B18/02A61B18/1206A61B90/06A61B5/01A61B5/042A61B18/1815A61B2018/00011A61B2018/00029A61B2018/00357A61B2018/00577A61B2018/00702A61B2018/00791A61B2018/00839A61B2018/00875A61B2018/00892A61B2018/00982A61B2018/126A61B2018/1417A61B2018/1467A61B2090/065A61B2218/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,893,903
App. No.
16/155,821
Filed
Oct 9, 2018
Granted
Jan 19, 2021
Kind
B2
Art Unit
3794
USPC
606/34
Abstract

Systems and methods for facilitating assessment of a nature of contact between an electrode assembly of an ablation catheter and viable body tissue are disclosed herein. In some embodiments, a method comprises obtaining a first detected voltage between a first electrode and a second electrode, wherein the first and second electrodes are positioned along an electrode assembly of the ablation catheter, and wherein the first electrode is distal to the second electrode, obtaining a second detected voltage between the second electrode and a third electrode, the third electrode positioned proximal to the second electrode.

Claims (51)

1. A system for ablating tissue and facilitating contact assessment between an electrode assembly and viable body tissue, comprising:

an ablation catheter;

an electrode assembly positioned along the ablation catheter; and

at least one additional electrode positioned along the ablation catheter;

a controller, the controller being configured to:

obtain a first detected voltage between a first electrode and a second electrode, the first and second electrodes are positioned along the electrode assembly, and the first electrode is distal to the second electrode;

obtain a second detected voltage between the second electrode and the at least one additional electrode, the at least one additional electrode being positioned proximal to the second electrode;

make a first comparison between the first detected voltage and a first threshold voltage, the first threshold voltage is indicative of a level of contact between viable body tissue and a first portion of the ablation catheter, the first portion of the ablation catheter positioned at a location between the first and second electrodes;

make a second comparison between the second detected voltage and a second threshold voltage, the second threshold voltage is indicative of a level of contact between viable body tissue and a second portion of the ablation catheter, the second portion of the ablation catheter positioned at a location between the second electrode and the at least one additional electrode;

determine the level of contact between viable body tissue and the first portion of the ablation catheter by comparing the first voltage to the first threshold voltage;

determine the level of contact between viable body tissue and the second portion of the ablation catheter by comparing the second voltage to the second threshold voltage; and

display a variably sized halo around a graphical representation of the electrode assembly, a size and shape of the halo indicating the level and location of contact between the first electrode and the second electrode and viable tissue, the halo defining an enclosed boundary about at least a portion of the electrode assembly and being displayed on a plane parallel to longitudinal axis of the electrode assembly.

2. The system of claim 1 , wherein at least one of the first threshold voltage and the second threshold voltage is 0.30 mV.

3. The system of claim 1 , wherein the first threshold voltage is the same as the second threshold voltage.

4. The system of claim 1 , wherein at least one of the first threshold voltage and the second threshold voltage is between 0.2 mV and 0.4 mV.

5. The system of claim 1 , wherein the halo comprises at least one parameter that is related to an intensity of contact between the electrode assembly and viable tissue.

6. The system of claim 1 , wherein the system is configured to make a determination regarding the orientation of the electrode assembly relative to viable body tissue.

7. The system of claim 6 , wherein making a determination regarding the orientation of the electrode assembly relative to viable body tissue comprises contrasting the first comparison to the second comparison.

8. A system for ablating tissue and facilitating contact assessment between an electrode assembly and viable body tissue, comprising:

an elongate member;

an electrode assembly comprising first and second electrodes; and at least one additional electrode;

a controller, the being configured to:

obtain a first detected voltage between the first electrode and the second electrode, wherein the first electrode is distal to the second electrode;

obtain a second detected voltage between the second electrode and the at least one additional electrode, the at least one additional electrode being positioned proximal to the second electrode;

make a first comparison between the first detected voltage and a first threshold voltage, the first threshold voltage is indicative of a level of contact between viable body tissue and a first portion of the elongate member, the first portion of the elongate member positioned at a location between the first and second electrodes;

make a second comparison between the second detected voltage and a second threshold voltage, the second threshold voltage is indicative of a level of contact between viable body tissue and a second portion of the elongate member, the second portion of the elongate member positioned at a location between the second electrode and the at least one additional electrode;

determine the level of contact between viable body tissue and the first portion of the elongate member by comparing the first voltage to the first threshold voltage; and

determine the level of contact between viable body tissue and the second portion of the elongate member by comparing the second to the second threshold voltage; and

display a variably sized halo around a graphical representation of the electrode assembly, a size and shape of the halo indicating the level and location of contact between the first electrode and the second electrode and viable tissue, the halo defining an enclosed boundary about at least a portion of the electrode assembly and being displayed on a plane parallel to longitudinal axis of the electrode assembly.

9. The system of claim 8 , wherein at least one of the first threshold voltage and the second threshold voltage is 0.30 mV.

10. The system of claim 8 , wherein at least one of the first threshold voltage and the second threshold voltage is between 0.2 mV and 0.4 mV.

11. The system of claim 8 , wherein the controller is configured to make a determination regarding the orientation of the electrode assembly relative to viable body tissue.

12. The system of claim 11 , wherein making a determination regarding the orientation of the electrode assembly relative to viable body tissue comprises contrasting the first comparison to the second comparison.

13. A system for ablating tissue and facilitating contact assessment between an electrode assembly and viable body tissue, comprising:

an elongate member;

a first electrode;

a second electrode proximal to the first electrode;

and at least one additional electrode; and

a controller being configured to:

obtain a first detected voltage between the first electrode and the second electrode;

obtain a second detected voltage between the second electrode and the at least one additional electrode, the at least one additional electrode being positioned proximal to the second electrode;

make a first comparison between the first detected voltage and a first threshold voltage, wherein the first threshold voltage is indicative of a level of contact between viable body tissue and a first portion of the elongate member, the first portion of the elongate member positioned at a location between the first and second electrodes;

the system is configured to make a second comparison between the second detected voltage and a second threshold voltage, wherein the second threshold voltage is indicative of a level of contact between viable body tissue and a second portion of the elongate member, the second portion of the elongate member positioned at a location between the second electrode and the at least one additional electrode;

contact between viable body tissue and the first portion of the elongate member is confirmed if the first voltage is at or above the first threshold voltage; and

contact between viable body tissue and the second portion of the elongate member is confirmed if the second voltage is at or above the second threshold voltage; and

display a variably sized halo around a graphical representation of the electrode assembly, a size and shape of the halo indicating the level and location of contact between the first portion of the elongate member and the second portion of the elongate member and viable tissue, the halo defining an enclosed boundary about at least a portion of the electrode assembly and being displayed on a plane parallel to longitudinal axis of the electrode assembly.

14. The system of claim 13 ,

wherein at least one of the first threshold voltage and the second threshold voltage is 0.30 mV.

15. The system of claim 13 , wherein at least one of the first threshold voltage and the second threshold voltage is between 0.2 mV and 0.4 mV.

16. The system of claim 13 , wherein the system is configured to make a determination regarding the orientation of the electrode assembly relative to viable body tissue.

17. The system of claim 16 , wherein making a determination regarding the orientation of the electrode assembly relative to viable body tissue comprises contrasting the first comparison to the second comparison.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: KOBLISH, JOSEF VINCENT; CHUN, DONGHOON; JOHNSON, JESSI E.
To: EPIX THERAPEUTICS, INC.
Reel/Frame 047127/0297 →
Continuity (4)
Continuation PCTUS2018029639 · Apr 26, 2018
Provisional Application 62491082 · Apr 27, 2017
Provisional Application 62536616 · Jul 25, 2017
Related Publication 20190038349A1 · Feb 7, 2019
Cited By (8)
US 12,279,801 US 12,622,716 US 12,622,718 US 12,661,136 US 12,702,433 US 12,708,385 US 12,714,449 US 12,714,450